Table 2.

Ovarian cancer patients included into the study

Sample no.	Age	Histologic subtype	Stage	TNM	Grading	Confounding diagnosis
1	47	Serous Adenocarcinoma	FIGO IIIc	pT3c, pN1, cM0	G3	None
2	53	Serous Adenocarcinoma	FIGO IIIc	pT2a, pN1, cM0	G3	Zoeliakie
3	56	Serous Adenocarcinoma	FIGO IIIc	pT3c, pN1, cM0	G3	None
4	76	Serous Adenocarcinoma	FIGO IV	pT3c, pN1, cM0	G3	Gastritis
5	48	Serous Adenocarcinoma	FIGO IIIc	pT3a, pN1, cM0	G3	Hypothyreosis
6	79	Serous Adenocarcinoma	FIGO IV	pT3c, pN1, cM0	G3	None
7	65	Serous Adenocarcinoma	FIGO IIIc	pT3c, pN1, cM0	G2	Esophagitis, bulbitis, gastritis
8	24	Sertoli-Leydig-Cell Tumor	FIGO Ia	pT1a, pN0, cM0	–	None
9	63	Serous Adenocarcinoma	FIGO IIa2	pT3a, pN1, cM1	G3	None
10	71	Serous Adenocarcinoma	FIGO IIIc	pT3c, pN1, cM0	G3	None
11	–	Serous Adenocarcinoma	–	–	–	–
12	–	Serous Adenocarcinoma	–	–	–	–
13	–	Serous Adenocarcinoma	–	–	–	–

TNM tumorstatus identified by pathologist, G grading, FIGO tumorstatus according to the French organization Fédération Internationale de Gynécologie et d'Obstétrique (FIGO)